FDC Ltd successfully completes USFDA inspection at Sterile facility, Waluj

FDC Ltd has announced that the manufacturing plant located at B-8, MIDC Industrial Area, Waluj, Aurangabad, Maharashtra, which manufactures sterile ophthalmic products, has been inspected by US FDA from 06th February to 12th February 2023.

The said audit has been successfully completed by the US FDA with "No observations" (Zero 483's).

The audit was carried out for the sterile ophthalmic products being marketed in the US.

Shares of FDC Limited was last trading in BSE at Rs. 266.90 as compared to the previous close of Rs. 264.85. The total number of shares traded during the day was 8710 in over 610 trades.

The stock hit an intraday high of Rs. 270.85 and intraday low of 263.95. The net turnover during the day was Rs. 2335410.00.

Source : Equity Bulls

Keywords

FDC INE258B01022 USFDA Inspection SterileFacility Waluj NoObservations OphthalmicProducts